Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in
developing and manufacturing interventional vascular technology, including the
drug-eluting Cypher stent. Through the company's innovation, research and
development, physicians worldwide are better able to treat the millions of people
who suffer from vascular disease.
Cordis Corporation
News
Australian adult stem cell company, Mesoblast Limited (ASX:MSB), today announced that Cordis Corporation, a Johnson & Johnson company, will join forces in its upcoming adult stem cell Pilot Cardiac Clinical Trial through an agreement with Mesoblast's American affiliated company, Angioblast Systems Inc.
###
884 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 9) (Since Published: 884)